Biotech Values

[DewDiligence]

GSK never gave a point estimate except to say their [RSV] data is “exceptional”. I don’t know if it’s still exceptional in light of the PFE data.

I would wager that GSK’s efficacy data is roughly as good as PFE’s. However, PFE’s tolerability may be better than GSK’s insofar as PFE’s vaccine does not include an adjuvant.